Status:

COMPLETED

Neurobiological Drivers of Mobility Resilience: The Dopaminergic System

Lead Sponsor:

University of Michigan

Collaborating Sponsors:

National Institute on Aging (NIA)

Conditions:

Parkinsonian Signs in Older Persons

Eligibility:

All Genders

60+ years

Phase:

PHASE1

PHASE2

Brief Summary

Walking with age becomes both slower and less 'automated', requiring more attention and brain resources. As a result, older adults have a greater risk of negative outcomes and falls. There is an urgen...

Detailed Description

Walking with age becomes both slower and less 'automated', requiring more attention and prefrontal resources. As a result older adults have a greater risk of adverse mobility outcomes and falls. Walki...

Eligibility Criteria

Inclusion

  • Age 60 or older (M/F)
  • Evidence of mild parkinsonian signs (incl. slow gait (\< 1m/s))

Exclusion

  • Presence of clinically significant degenerative joint disease and/or neuropathy interfering with proper assessment of the motor UPDRS exam.
  • Presence of significant dementia.
  • Evidence of a large vessel stroke in a clinically relevant area (cerebral cortex, basal ganglia, thalamus) or mass lesion on structural brain imaging (MRI).
  • Participants in whom magnetic resonance imaging (MRI) is contraindicated including, but not limited to, those with a pacemaker, presence of metallic fragments near the eyes or spinal cord, or cochlear implant.
  • Severe claustrophobia precluding neuroimaging procedures.
  • Hypersensitivity to the carbidopa, levodopa, and tablet components.
  • Any other medical history determined by investigators to preclude safe participation.

Key Trial Info

Start Date :

February 8 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2022

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT04325503

Start Date

February 8 2021

End Date

June 30 2022

Last Update

April 4 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Functional Neuroimaging, Cognitive, and Mobility Lab, University of Michigan

Ann Arbor, Michigan, United States, 48105